Table 2 Clinical and histopathological characteristics of patients with urothelial carcinoma and of controls (healthy donors (n=25), prostate cancer (n=25) and renal cancer (n=25) patients), which provided urine samples for this study
From: MicroRNA promoter methylation: a new tool for accurate detection of urothelial carcinoma
Clinicopathological features | UC | Control set | P -value |
|---|---|---|---|
Patients, n | 49 | 75 | |
Gender, n (%) | |||
Male | 29 (60%) | 53 (71%) | |
Female | 20 (40%) | 22 (29%) | |
Median age, years (range) | 70 (53–83) | 63 (51–88) | P<0.066 |
Grade, n (%) | |||
Papillary, low grade | 17 (35%) | NA | |
Papillary, high grade | 18 (37%) | NA | |
Invasive, high grade | 14 (28%) | NA |
